West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, has relocated to a new office facility in Seoul, South Korea and expanded its warehouse capacity. This is part of West's ongoing investment in the Asia Pacific region and strategically positions West in key markets with enhanced scalability to support the future growth needs of its customers.

The newly enhanced office space is in the commercial centre of Seoul and will enable West to foster deeper collaboration with existing and new customers through a dedicated training area that will host customer training, seminars, and technical exchange sessions on topics such as the evolving regulatory requirements around the world, particularly in the areas of drug safety and packaging.

This expansion comes nearly one year after West announced its upgraded manufacturing facility in Jurong, Singapore, that now has capabilities to manufacture a comprehensive range of advanced containment products to meet the evolving needs of sensitive and complex molecules.

West’s new warehouse facility is strategically located in Hwaseong, close to the major local pharmaceutical companies. The warehouse space is 3,442.51m², doubling the previous storage, enhancing West's inventory management capability to meet the growing supply needs of the region in support of South Korea's ambition to become a key player in the global biologics market. This strategic move comes at a time when South Korea is emerging as a global biologic’s hub, with the government committed to quintupling the country’s biotechnology industrial output by 2035.

Image caption- Left to Right: Jenny Park, National Sales Manager, Korea; Nilesh Shah, Vice President and General Manager of Emerging Markets; Cindy Reiss-Clark, Chief Commercial Officer; Journey Hong, General Manager, Korea; Kok Li Kwang, Director, Scientific Affairs & Technical Services, Asia Pacific